StockData
SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

SpyGlass Pharma, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$24.60+0.60 (+2.50%)

Close on Oct 19, 2026

Market cap
$822.61M
P/E (TTM)
–
Dividend yield
–

SEC filings

11 of SpyGlass Pharma's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report8-KOct 19, 2026Oct 19, 2026SEC EDGAR
Current report8-KOct 1, 2026Oct 1, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 6, 2026SEC EDGAR
Current report8-KAug 6, 2026Aug 6, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 14, 2026SEC EDGAR
Current report8-KMay 14, 2026May 14, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 26, 2026SEC EDGAR
Current report8-KMar 26, 2026Mar 26, 2026SEC EDGAR
Current report8-KMar 9, 2026Mar 9, 2026SEC EDGAR
Current report8-KFeb 12, 2026Feb 13, 2026SEC EDGAR
Current report8-KFeb 5, 2026Feb 9, 2026SEC EDGAR